KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Global Medical REIT (GMRE) over the last 12 years, with Q3 2025 value amounting to $11.2 million.

  • Global Medical REIT's Depreciation & Amortization (CF) rose 1220.85% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.0 million, marking a year-over-year increase of 639.02%. This contributed to the annual value of $40.4 million for FY2024, which is 203.32% down from last year.
  • Global Medical REIT's Depreciation & Amortization (CF) amounted to $11.2 million in Q3 2025, which was up 1220.85% from $11.3 million recorded in Q2 2025.
  • In the past 5 years, Global Medical REIT's Depreciation & Amortization (CF) registered a high of $11.3 million during Q2 2025, and its lowest value of $7.8 million during Q1 2021.
  • Its 5-year average for Depreciation & Amortization (CF) is $9.9 million, with a median of $10.1 million in 2024.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first soared by 3447.57% in 2021, then tumbled by 363.06% in 2024.
  • Global Medical REIT's Depreciation & Amortization (CF) (Quarter) stood at $9.0 million in 2021, then rose by 16.96% to $10.6 million in 2022, then decreased by 3.55% to $10.2 million in 2023, then dropped by 0.1% to $10.2 million in 2024, then increased by 10.0% to $11.2 million in 2025.
  • Its Depreciation & Amortization (CF) was $11.2 million in Q3 2025, compared to $11.3 million in Q2 2025 and $10.3 million in Q1 2025.